Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
and Commission regulation EC 440/2008 and EPA 712-C-98-247
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Colchicoside
EC Number:
207-513-0
EC Name:
Colchicoside
Cas Number:
477-29-2
Molecular formula:
C27H33NO11
IUPAC Name:
N-[1,2,10-trimethoxy-9-oxo-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6,7-dihydro-5H-benzo[d]heptalen-7-yl]acetamide

Method

Target gene:
Bacterial reverse mutation assay use amino acid requiring strains of Salmonella typhimurium to detect point mutations, which involve substitution, addition or deletion of one or a few DNA base pairs. The principle of these bacterial reversion assay is that they detect mutations which functionally reverse mutations present in the tester strains and restore the capability to synthesise an essential amino acid. The purpose of this study is to establish the potential of the test item to induce gene mutations in bacteria by means of two independent S. typhimurium reverse mutation assay.
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
S. typhimurium TA 102
Metabolic activation:
with and without
Metabolic activation system:
S9 mix
Test concentrations with justification for top dose:
31.6, 100, 316, 1000, 2500 and 5000 microg/plate
Vehicle / solvent:
Distilled water and DMSO

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

In order to investigate the potential of COLCHICOSIDE for its ability to induce gene mutations the plate incorporation test and the pre-incubation test were performed with the Salmonella typhimurium strains. In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation. The concentrations, including the controls, were tested in triplicate. No toxic effects of the test item were noted in any of the five tester strains used up to the highest dose group evaluated. No biologically relevant increases in revertant colony number of any of the five concentration level, neither in the presence nor absence of metabolic activation. The reference mutagens induced a distinct increase of revertant colonies indicating the validity of the experiments.

n order to investigate the potential of COLCHICOSIDE for its ability to induce gene mutations the plate incorporation test and the pre-incubation test were performed with the Salmonella typhimurium strains. In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation. The concentrations, including the controls, were tested in triplicate. No toxic effects of the test item were noted in any of the five tester strains used up to the highest dose group evaluated. No biologically relevant increases in revertant colony number of any of the five concentration level, neither in the presence nor absence of metabolic activation. The reference mutagens induced a distinct increase of revertant colonies indicating the validity of the experiments.

In order to investigate the potential of COLCHICOSIDE for its ability to induce gene mutations the plate incorporation test and the pre-incubation test were performed with the Salmonella typhimurium strains. In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation. The concentrations, including the controls, were tested in triplicate. No toxic effects of the test item were noted in any of the five tester strains used up to the highest dose group evaluated. No biologically relevant increases in revertant colony number of any of the five concentration level, neither in the presence nor absence of metabolic activation. The reference mutagens induced a distinct increase of revertant colonies indicating the validity of the experiments.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation

It is concluded that the test item Colchicoside did not cause gene mutations by base pair changes or frameshifts in the genome of Salmonella typhimurium strains used.
Therefore, Colchicoside is considered to be non-mutagenic in this bacterial reverse mutation assay.